MTOR and mantle cell lymphoma: For example, vorinostat suppresses cyclin D1 in mantle cell lymphoma cells by blocking the translation of cyclin D1 via inhibiting the phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR/eIF4E-BP pathway most likely by PI3K inhibition [14].